Pembrolizumab was associated with high response rates in surgically unresectable advanced desmoplastic melanoma.

This article highlights recent research on breast cancer, lung cancer, melanoma, head and neck cancer, and hematologic malignancies.

Correspondingly, the clinical treatment of melanoma continues to evolve. In light of these changes in available systemic therapy options, a thorough and comprehensive guideline on systemic therapy for ...